Homotypic Cell to Cell Cross-talk Among Human Natural Killer Cells Reveals Differential and Overlapping Roles of 2B4 and CD2

Human natural killer (NK) cells express an abundant level of 2B4 and CD2 on their surface. Their counter-receptors, CD48 and CD58, are also expressed on the NK cell surface, raising a question about the functional consequences of potential 2B4/CD48 and CD2/CD58 interactions. Using blocking antibodie...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 285; no. 53; pp. 41755 - 41764
Main Authors Kim, Eun-Ok, Kim, Tae-Jin, Kim, Nayoung, Kim, Sung Tae, Kumar, Vinay, Lee, Kyung-Mi
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 31.12.2010
American Society for Biochemistry and Molecular Biology
Subjects
Online AccessGet full text
ISSN0021-9258
1083-351X
1083-351X
DOI10.1074/jbc.M110.137976

Cover

Abstract Human natural killer (NK) cells express an abundant level of 2B4 and CD2 on their surface. Their counter-receptors, CD48 and CD58, are also expressed on the NK cell surface, raising a question about the functional consequences of potential 2B4/CD48 and CD2/CD58 interactions. Using blocking antibodies specific to each receptor, we demonstrated that both 2B4/CD48 and CD2/CD58 interactions were essential for the development of NK effector functions: cytotoxicity and cytokine secretion. However, only 2B4/CD48, but not CD2/CD58, interactions were shown to be critical for the optimal NK cell proliferation in response to interleukin (IL)-2. IL-2-activated NK cells cultured in the absence of 2B4/CD48 or CD2/CD58 interactions were severely impaired for their ability to induce intracellular calcium mobilization and subsequent ERK activation upon tumor target exposure, suggesting that the early signaling pathway of NK receptors leading to impaired cytolysis and interferon (IFN)-γ secretion was inhibited. Nevertheless, these defects did not fully account for the reduced proliferation of NK cells in the absence of 2B4/CD48 interactions, because anti-CD2 or anti-CD58 monoclonal antibody (mAb)-treated NK cells, showing defective signaling and effector functions, displayed normal proliferation upon IL-2 stimulation. These results propose the signaling divergence between pathways leading to cell proliferation and cytotoxicity/cytokine release, which can be differentially regulated by 2B4 and CD2 during IL-2-driven NK cell activation. Collectively, these results reveal the importance of homotypic NK-to-NK cell cross-talk through 2B4/CD48 and CD2/CD58 pairs and further present their differential and overlapping roles in human NK cells.
AbstractList Human natural killer (NK) cells express an abundant level of 2B4 and CD2 on their surface. Their counter-receptors, CD48 and CD58, are also expressed on the NK cell surface, raising a question about the functional consequences of potential 2B4/CD48 and CD2/CD58 interactions. Using blocking antibodies specific to each receptor, we demonstrated that both 2B4/CD48 and CD2/CD58 interactions were essential for the development of NK effector functions: cytotoxicity and cytokine secretion. However, only 2B4/CD48, but not CD2/CD58, interactions were shown to be critical for the optimal NK cell proliferation in response to interleukin (IL)-2. IL-2-activated NK cells cultured in the absence of 2B4/CD48 or CD2/CD58 interactions were severely impaired for their ability to induce intracellular calcium mobilization and subsequent ERK activation upon tumor target exposure, suggesting that the early signaling pathway of NK receptors leading to impaired cytolysis and interferon (IFN)-γ secretion was inhibited. Nevertheless, these defects did not fully account for the reduced proliferation of NK cells in the absence of 2B4/CD48 interactions, because anti-CD2 or anti-CD58 monoclonal antibody (mAb)-treated NK cells, showing defective signaling and effector functions, displayed normal proliferation upon IL-2 stimulation. These results propose the signaling divergence between pathways leading to cell proliferation and cytotoxicity/cytokine release, which can be differentially regulated by 2B4 and CD2 during IL-2-driven NK cell activation. Collectively, these results reveal the importance of homotypic NK-to-NK cell cross-talk through 2B4/CD48 and CD2/CD58 pairs and further present their differential and overlapping roles in human NK cells.
Human natural killer (NK) cells express an abundant level of 2B4 and CD2 on their surface. Their counter-receptors, CD48 and CD58, are also expressed on the NK cell surface, raising a question about the functional consequences of potential 2B4/CD48 and CD2/CD58 interactions. Using blocking antibodies specific to each receptor, we demonstrated that both 2B4/CD48 and CD2/CD58 interactions were essential for the development of NK effector functions: cytotoxicity and cytokine secretion. However, only 2B4/CD48, but not CD2/CD58, interactions were shown to be critical for the optimal NK cell proliferation in response to interleukin (IL)-2. IL-2-activated NK cells cultured in the absence of 2B4/CD48 or CD2/CD58 interactions were severely impaired for their ability to induce intracellular calcium mobilization and subsequent ERK activation upon tumor target exposure, suggesting that the early signaling pathway of NK receptors leading to impaired cytolysis and interferon (IFN)- gamma secretion was inhibited. Nevertheless, these defects did not fully account for the reduced proliferation of NK cells in the absence of 2B4/CD48 interactions, because anti-CD2 or anti-CD58 monoclonal antibody (mAb)-treated NK cells, showing defective signaling and effector functions, displayed normal proliferation upon IL-2 stimulation. These results propose the signaling divergence between pathways leading to cell proliferation and cytotoxicity/cytokine release, which can be differentially regulated by 2B4 and CD2 during IL-2-driven NK cell activation. Collectively, these results reveal the importance of homotypic NK-to-NK cell cross-talk through 2B4/CD48 and CD2/CD58 pairs and further present their differential and overlapping roles in human NK cells.
Human natural killer (NK) cells express an abundant level of 2B4 and CD2 on their surface. Their counter-receptors, CD48 and CD58, are also expressed on the NK cell surface, raising a question about the functional consequences of potential 2B4/CD48 and CD2/CD58 interactions. Using blocking antibodies specific to each receptor, we demonstrated that both 2B4/CD48 and CD2/CD58 interactions were essential for the development of NK effector functions: cytotoxicity and cytokine secretion. However, only 2B4/CD48, but not CD2/CD58, interactions were shown to be critical for the optimal NK cell proliferation in response to interleukin (IL)-2. IL-2-activated NK cells cultured in the absence of 2B4/CD48 or CD2/CD58 interactions were severely impaired for their ability to induce intracellular calcium mobilization and subsequent ERK activation upon tumor target exposure, suggesting that the early signaling pathway of NK receptors leading to impaired cytolysis and interferon (IFN)-γ secretion was inhibited. Nevertheless, these defects did not fully account for the reduced proliferation of NK cells in the absence of 2B4/CD48 interactions, because anti-CD2 or anti-CD58 monoclonal antibody (mAb)-treated NK cells, showing defective signaling and effector functions, displayed normal proliferation upon IL-2 stimulation. These results propose the signaling divergence between pathways leading to cell proliferation and cytotoxicity/cytokine release, which can be differentially regulated by 2B4 and CD2 during IL-2-driven NK cell activation. Collectively, these results reveal the importance of homotypic NK-to-NK cell cross-talk through 2B4/CD48 and CD2/CD58 pairs and further present their differential and overlapping roles in human NK cells.Human natural killer (NK) cells express an abundant level of 2B4 and CD2 on their surface. Their counter-receptors, CD48 and CD58, are also expressed on the NK cell surface, raising a question about the functional consequences of potential 2B4/CD48 and CD2/CD58 interactions. Using blocking antibodies specific to each receptor, we demonstrated that both 2B4/CD48 and CD2/CD58 interactions were essential for the development of NK effector functions: cytotoxicity and cytokine secretion. However, only 2B4/CD48, but not CD2/CD58, interactions were shown to be critical for the optimal NK cell proliferation in response to interleukin (IL)-2. IL-2-activated NK cells cultured in the absence of 2B4/CD48 or CD2/CD58 interactions were severely impaired for their ability to induce intracellular calcium mobilization and subsequent ERK activation upon tumor target exposure, suggesting that the early signaling pathway of NK receptors leading to impaired cytolysis and interferon (IFN)-γ secretion was inhibited. Nevertheless, these defects did not fully account for the reduced proliferation of NK cells in the absence of 2B4/CD48 interactions, because anti-CD2 or anti-CD58 monoclonal antibody (mAb)-treated NK cells, showing defective signaling and effector functions, displayed normal proliferation upon IL-2 stimulation. These results propose the signaling divergence between pathways leading to cell proliferation and cytotoxicity/cytokine release, which can be differentially regulated by 2B4 and CD2 during IL-2-driven NK cell activation. Collectively, these results reveal the importance of homotypic NK-to-NK cell cross-talk through 2B4/CD48 and CD2/CD58 pairs and further present their differential and overlapping roles in human NK cells.
Author Kim, Eun-Ok
Kim, Nayoung
Kim, Tae-Jin
Lee, Kyung-Mi
Kim, Sung Tae
Kumar, Vinay
Author_xml – sequence: 1
  givenname: Eun-Ok
  surname: Kim
  fullname: Kim, Eun-Ok
  organization: Department of Biochemistry and Division of Brain Korea 21 Program for Biomedical Science, Global Research Lab, Korea University College of Medicine, Seoul, Korea
– sequence: 2
  givenname: Tae-Jin
  surname: Kim
  fullname: Kim, Tae-Jin
  organization: Department of Biochemistry and Division of Brain Korea 21 Program for Biomedical Science, Global Research Lab, Korea University College of Medicine, Seoul, Korea
– sequence: 3
  givenname: Nayoung
  surname: Kim
  fullname: Kim, Nayoung
  organization: Department of Biochemistry and Division of Brain Korea 21 Program for Biomedical Science, Global Research Lab, Korea University College of Medicine, Seoul, Korea
– sequence: 4
  givenname: Sung Tae
  surname: Kim
  fullname: Kim, Sung Tae
  organization: Department of Biochemistry and Division of Brain Korea 21 Program for Biomedical Science, Global Research Lab, Korea University College of Medicine, Seoul, Korea
– sequence: 5
  givenname: Vinay
  surname: Kumar
  fullname: Kumar, Vinay
  organization: Department of Pathology, University of Chicago, Chicago, Illinois 60637
– sequence: 6
  givenname: Kyung-Mi
  surname: Lee
  fullname: Lee, Kyung-Mi
  email: kyunglee@korea.ac.kr
  organization: Department of Biochemistry and Division of Brain Korea 21 Program for Biomedical Science, Global Research Lab, Korea University College of Medicine, Seoul, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20813844$$D View this record in MEDLINE/PubMed
BookMark eNqFUlFr1TAYDTJxd9Nn3yRvPnVLmrRNXoTZqVecDoaCbyFNv87MtqlJemHgjze93USFYV4O4TvncD6-c4QORjcCQs8pOaGk4qc3jTn5SJcfq2RVPkIbSgTLWEG_HqANITnNZF6IQ3QUwg1Jj0v6BB3mRFAmON-gn1s3uHg7WYNr6Hsc3Yq1dyFkUfff8dngxmu8nQc94k86zl73-IPte_B7asBXsAOd8Nx2HXgYo00MPbb4cge-19Nkk_7K9RCw63D-mu-H9Xn-FD3ukhCe3eEx-vL2zed6m11cvntfn11khlc8ZrJoTac7XgJviwYKbgrWcWm4KYkxUJqmolXFRElNA8JIKDRrytaIllIhaceO0avVd5qbAVqTIqYl1OTtoP2tctqqvyej_aau3U4xQqQkLBm8vDPw7scMIarBBpOW1yO4OShRcSpImUL8l5lTLgTde774M9TvNPe3SYRiJZjlFh46ZWzU0bolo-0VJWrpgEodUEsH1NqBpDv9R3dv_bBCrgpIR9hZ8CoYC6OB1nowUbXOPqj9BVKdyCU
CitedBy_id crossref_primary_10_1016_j_mrrev_2014_10_002
crossref_primary_10_4049_jimmunol_1701240
crossref_primary_10_3389_fimmu_2018_02809
crossref_primary_10_1002_eji_201847931
crossref_primary_10_1016_j_jcyt_2023_07_002
crossref_primary_10_3389_fimmu_2023_1174138
crossref_primary_10_1002_eji_201343724
crossref_primary_10_1016_j_jprot_2013_06_024
crossref_primary_10_1371_journal_pone_0047664
crossref_primary_10_1016_j_jaci_2019_07_038
crossref_primary_10_1093_jrr_rrs037
crossref_primary_10_3390_ijms25031556
crossref_primary_10_3389_fimmu_2019_00879
crossref_primary_10_1002_eji_201646492
crossref_primary_10_3389_fimmu_2020_568927
crossref_primary_10_1111_imr_12021
crossref_primary_10_1371_journal_pone_0097844
crossref_primary_10_1038_s41598_024_52606_2
crossref_primary_10_1186_s13027_015_0043_8
crossref_primary_10_1016_j_cyto_2017_02_005
crossref_primary_10_18632_oncotarget_13660
Cites_doi 10.4049/jimmunol.162.12.6981
10.1152/ajpgi.90497.2008
10.1182/blood-2009-08-238469
10.4049/jimmunol.180.12.8159
10.1093/intimm/dxh358
10.1016/j.imlet.2006.02.006
10.4049/jimmunol.148.7.2023
10.1073/pnas.0604236103
10.4049/jimmunol.179.12.8009
10.1084/jem.20031989
10.4049/jimmunol.175.7.4226
10.1002/eji.200636341
10.4049/jimmunol.175.4.2045
10.1016/j.molimm.2008.03.021
10.1084/jem.178.4.1397
10.4049/jimmunol.167.12.6706
10.1073/pnas.92.15.6728
10.1084/jem.190.10.1383
10.1016/j.molimm.2004.07.032
10.1016/j.jim.2004.08.008
10.1111/j.1600-065X.2006.00453.x
10.1016/S0301-472X(00)00652-4
10.3858/emm.2009.41.3.019
10.4049/jimmunol.0901572
10.1182/blood-2004-08-3269
10.1002/(SICI)1521-4141(199905)29:05<1676::AID-IMMU1676>3.0.CO;2-Y
10.4049/jimmunol.173.1.174
10.1182/blood-2009-01-201632
10.1084/jem.188.11.2083
10.1182/blood-2002-07-2206
10.1083/jcb.200809136
10.1074/jbc.M807053200
10.1182/blood-2004-09-3796
10.1016/j.molimm.2004.07.021
10.4049/jimmunol.176.8.4646
10.1182/blood-2005-01-0185
10.1002/eji.200838733
10.1038/317428a0
10.4049/jimmunol.167.11.6210
10.1093/intimm/dxl141
10.4049/jimmunol.174.2.800
10.1182/blood-2007-02-076927
ContentType Journal Article
Copyright 2010 © 2010 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.
2010 by The American Society for Biochemistry and Molecular Biology, Inc.
Copyright_xml – notice: 2010 © 2010 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.
– notice: 2010 by The American Society for Biochemistry and Molecular Biology, Inc.
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
H94
5PM
DOI 10.1074/jbc.M110.137976
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Immunology Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList
AIDS and Cancer Research Abstracts

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
DocumentTitleAlternate Cell to Cell Cross-talk through 2B4 and CD2
EISSN 1083-351X
EndPage 41764
ExternalDocumentID PMC3009903
20813844
10_1074_jbc_M110_137976
S0021925819761614
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-DZ
-ET
-~X
0SF
18M
29J
2WC
34G
39C
4.4
53G
5BI
5GY
5RE
5VS
6I.
79B
85S
AAEDW
AAFTH
AAFWJ
AARDX
AAXUO
ABDNZ
ABOCM
ABPPZ
ABRJW
ACGFO
ACNCT
ADBBV
ADIYS
ADNWM
AENEX
AEXQZ
AFFNX
AFOSN
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
BAWUL
BTFSW
C1A
CJ0
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FDB
FRP
GROUPED_DOAJ
GX1
HH5
HYE
IH2
KQ8
L7B
N9A
OK1
P-O
P0W
P2P
R.V
RHF
RHI
RNS
ROL
RPM
SJN
TBC
TN5
TR2
UHB
UKR
UPT
VQA
W8F
WH7
WOQ
XFK
XSW
YQT
YSK
YWH
YZZ
ZA5
ZE2
~02
~KM
.55
.7T
.GJ
0R~
186
3O-
41~
6TJ
AALRI
AAYJJ
AAYOK
AAYWO
AAYXX
ABFSI
ACSFO
ACVFH
ACYGS
ADCNI
ADVLN
ADXHL
AEUPX
AFPUW
AI.
AIGII
AITUG
AKBMS
AKRWK
AKYEP
CITATION
E.L
FA8
H13
J5H
MVM
NHB
OHT
QZG
UQL
VH1
WHG
X7M
XJT
Y6R
YYP
ZGI
ZY4
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
H94
5PM
ID FETCH-LOGICAL-c474t-95dcfaf46e4d5be54c53f49c4c60cce6cb71773861cbe8c9e5a3b6dc8d11891f3
ISSN 0021-9258
1083-351X
IngestDate Thu Aug 21 18:14:01 EDT 2025
Fri Sep 05 09:10:08 EDT 2025
Fri Sep 05 06:24:13 EDT 2025
Wed Mar 19 04:48:45 EDT 2025
Thu Apr 24 23:06:53 EDT 2025
Tue Jul 01 01:53:45 EDT 2025
Fri Feb 23 02:45:46 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 53
Keywords CD2
Receptors
Immunology
2B4
Cell-Cell Interaction
Innate Immunity
NK Cells
CD48
Cellular Immune Response
CD58
Language English
License This is an open access article under the CC BY license.
http://creativecommons.org/licenses/by/4.0
https://www.elsevier.com/tdm/userlicense/1.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c474t-95dcfaf46e4d5be54c53f49c4c60cce6cb71773861cbe8c9e5a3b6dc8d11891f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Supported by Seoul R&BD Program Grant 10920.
Supported by the National Nuclear R&D program grant BAERI.
Both authors contributed equally to this paper.
Supported by Innovative Research Institute for Cell Therapy Grant A062260.
OpenAccessLink https://dx.doi.org/10.1074/jbc.M110.137976
PMID 20813844
PQID 821488103
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3009903
proquest_miscellaneous_874180677
proquest_miscellaneous_821488103
pubmed_primary_20813844
crossref_citationtrail_10_1074_jbc_M110_137976
crossref_primary_10_1074_jbc_M110_137976
elsevier_sciencedirect_doi_10_1074_jbc_M110_137976
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-12-31
PublicationDateYYYYMMDD 2010-12-31
PublicationDate_xml – month: 12
  year: 2010
  text: 2010-12-31
  day: 31
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 9650 Rockville Pike, Bethesda, MD 20814, U.S.A
PublicationTitle The Journal of biological chemistry
PublicationTitleAlternate J Biol Chem
PublicationYear 2010
Publisher Elsevier Inc
American Society for Biochemistry and Molecular Biology
Publisher_xml – name: Elsevier Inc
– name: American Society for Biochemistry and Molecular Biology
References Siliciano, Pratt, Schmidt, Ritz, Reinherz (bib33) 1985; 317
Wahle, Paraiso, Kendig, Lawrence, Chen, Wu, Kerr (bib38) 2007; 179
Bryceson, Ljunggren, Long (bib29) 2009; 114
Mathew, Rao, Kim, Bambard, Mathew (bib20) 2009; 39
Assarsson, Kambayashi, Persson, Ljunggren, Chambers (bib8) 2005; 42
Messmer, Eissmann, Stark, Watzl (bib22) 2006; 176
Veillette (bib2) 2006; 214
Crawford, Stark, Kitchens, Sternheim, Pantazopoulos, Triantafellow, Wang, Vasir, Larsen, Gabuzda, Reinherz, Alper (bib30) 2003; 102
Assarsson, Kambayashi, Persson, Chambers, Ljunggren (bib9) 2005; 175
Espagnolle, Depoil, Zaru, Demeur, Champagne, Guiraud, Valitutti (bib31) 2007; 19
Nakajima, Cella, Langen, Friedlein, Colonna (bib14) 1999; 29
Mahajan, Gollob, Ritz, Frank (bib4) 2001; 29
Kaizuka, Douglass, Vardhana, Dustin, Vale (bib35) 2009; 185
Kanner, Damle, Blake, Aruffo, Ledbetter (bib34) 1992; 148
Stark, Watzl (bib19) 2006; 18
Betser-Cohen, Mizrahi, Elboim, Alsheich-Bartok, Mandelboim (bib27) 2010; 184
Saborit-Villarroya, Martinez-Barriocanal, Oliver-Vila, Engel, Sayos, Martin (bib40) 2008; 45
Saborit-Villarroya, Del Valle, Romero, Esplugues, Lauzurica, Engel, Martín (bib24) 2005; 175
Bachmann, Barner, Kopf (bib32) 1999; 190
Brown, Boles, van der Merwe, Kumar, Mathew, Barclay (bib6) 1998; 188
Tangye, Lazetic, Woollatt, Sutherland, Lanier, Phillips (bib13) 1999; 162
Chen, Allan, Krzewski, Ge, Kopcow, Strominger (bib25) 2006; 103
Vaidya, Stepp, McNerney, Lee, Bennett, Lee, Stewart, Kumar, Mathew (bib3) 2005; 174
Lee, Forman, McNerney, Stepp, Kuppireddi, Guzior, Latchman, Sayegh, Yagita, Park, Oh, Wülfing, Schatzle, Mathew, Sharpe, Kumar (bib7) 2006; 107
Endt, Eissmann, Hoffmann, Meinke, Giese, Watzl (bib41) 2007; 37
Yoon, Yun, Park, Won, Kim, Sohn, Cho, Kim (bib18) 2009; 41
Vaidya, Mathew (bib21) 2006; 105
Assarsson, Kambayashi, Schatzle, Cramer, von Bonin, Jensen, Ljunggren, Chambers (bib11) 2004; 173
Valiante, Trinchieri (bib5) 1993; 178
Lee, McNerney, Stepp, Mathew, Schatzle, Bennett, Kumar (bib12) 2004; 199
Fauriat, Long, Ljunggren, Bryceson (bib28) 2010; 115
Taniguchi, Guzior, Kumar (bib26) 2007; 110
Chlewicki, Velikovsky, Balakrishnan, Mariuzza, Kumar (bib42) 2008; 180
Alter, Malenfant, Altfeld (bib17) 2004; 294
McNerney, Lee, Kumar (bib1) 2005; 42
Zheng, Wang, Wei, Sun, Tian (bib37) 2009; 284
Sadelain, Wang, Antoniou, Grosveld, Mulligan (bib16) 1995; 92
Ebert, Panja, Praveen (bib36) 2009; 296
Dupré, Andolfi, Tangye, Clementi, Locatelli, Aricò, Aiuti, Roncarolo (bib15) 2005; 105
Chuang, Kumaresan, Mathew (bib23) 2001; 167
Kambayashi, Assarsson, Chambers, Ljunggren (bib10) 2001; 167
Eissmann, Beauchamp, Wooters, Tilton, Long, Watzl (bib39) 2005; 105
Dupré (10.1074/jbc.M110.137976_bib15) 2005; 105
Eissmann (10.1074/jbc.M110.137976_bib39) 2005; 105
Tangye (10.1074/jbc.M110.137976_bib13) 1999; 162
Lee (10.1074/jbc.M110.137976_bib7) 2006; 107
Crawford (10.1074/jbc.M110.137976_bib30) 2003; 102
Chen (10.1074/jbc.M110.137976_bib25) 2006; 103
Veillette (10.1074/jbc.M110.137976_bib2) 2006; 214
Chlewicki (10.1074/jbc.M110.137976_bib42) 2008; 180
Assarsson (10.1074/jbc.M110.137976_bib9) 2005; 175
Assarsson (10.1074/jbc.M110.137976_bib8) 2005; 42
Yoon (10.1074/jbc.M110.137976_bib18) 2009; 41
Betser-Cohen (10.1074/jbc.M110.137976_bib27) 2010; 184
McNerney (10.1074/jbc.M110.137976_bib1) 2005; 42
Bachmann (10.1074/jbc.M110.137976_bib32) 1999; 190
Kaizuka (10.1074/jbc.M110.137976_bib35) 2009; 185
Alter (10.1074/jbc.M110.137976_bib17) 2004; 294
Lee (10.1074/jbc.M110.137976_bib12) 2004; 199
Wahle (10.1074/jbc.M110.137976_bib38) 2007; 179
Vaidya (10.1074/jbc.M110.137976_bib3) 2005; 174
Fauriat (10.1074/jbc.M110.137976_bib28) 2010; 115
Saborit-Villarroya (10.1074/jbc.M110.137976_bib40) 2008; 45
Ebert (10.1074/jbc.M110.137976_bib36) 2009; 296
Mathew (10.1074/jbc.M110.137976_bib20) 2009; 39
Sadelain (10.1074/jbc.M110.137976_bib16) 1995; 92
Zheng (10.1074/jbc.M110.137976_bib37) 2009; 284
Siliciano (10.1074/jbc.M110.137976_bib33) 1985; 317
Messmer (10.1074/jbc.M110.137976_bib22) 2006; 176
Bryceson (10.1074/jbc.M110.137976_bib29) 2009; 114
Assarsson (10.1074/jbc.M110.137976_bib11) 2004; 173
Nakajima (10.1074/jbc.M110.137976_bib14) 1999; 29
Stark (10.1074/jbc.M110.137976_bib19) 2006; 18
Kambayashi (10.1074/jbc.M110.137976_bib10) 2001; 167
Brown (10.1074/jbc.M110.137976_bib6) 1998; 188
Endt (10.1074/jbc.M110.137976_bib41) 2007; 37
Saborit-Villarroya (10.1074/jbc.M110.137976_bib24) 2005; 175
Vaidya (10.1074/jbc.M110.137976_bib21) 2006; 105
Taniguchi (10.1074/jbc.M110.137976_bib26) 2007; 110
Espagnolle (10.1074/jbc.M110.137976_bib31) 2007; 19
Mahajan (10.1074/jbc.M110.137976_bib4) 2001; 29
Kanner (10.1074/jbc.M110.137976_bib34) 1992; 148
Valiante (10.1074/jbc.M110.137976_bib5) 1993; 178
Chuang (10.1074/jbc.M110.137976_bib23) 2001; 167
References_xml – volume: 103
  start-page: 10346
  year: 2006
  end-page: 10351
  ident: bib25
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
– volume: 110
  start-page: 2020
  year: 2007
  end-page: 2023
  ident: bib26
  publication-title: Blood.
– volume: 41
  start-page: 161
  year: 2009
  end-page: 170
  ident: bib18
  publication-title: Exp. Mol. Med.
– volume: 167
  start-page: 6210
  year: 2001
  end-page: 6216
  ident: bib23
  publication-title: J. Immunol.
– volume: 284
  start-page: 21280
  year: 2009
  end-page: 21287
  ident: bib37
  publication-title: J. Biol. Chem.
– volume: 105
  start-page: 4383
  year: 2005
  end-page: 4389
  ident: bib15
  publication-title: Blood.
– volume: 19
  start-page: 239
  year: 2007
  end-page: 248
  ident: bib31
  publication-title: Int. Immunol.
– volume: 188
  start-page: 2083
  year: 1998
  end-page: 2090
  ident: bib6
  publication-title: J. Exp. Med.
– volume: 45
  start-page: 3446
  year: 2008
  end-page: 3453
  ident: bib40
  publication-title: Mol. Immunol.
– volume: 178
  start-page: 1397
  year: 1993
  end-page: 1406
  ident: bib5
  publication-title: J. Exp. Med.
– volume: 18
  start-page: 241
  year: 2006
  end-page: 247
  ident: bib19
  publication-title: Int. Immunol.
– volume: 180
  start-page: 8159
  year: 2008
  end-page: 8167
  ident: bib42
  publication-title: J. Immunol.
– volume: 105
  start-page: 4722
  year: 2005
  end-page: 4729
  ident: bib39
  publication-title: Blood.
– volume: 175
  start-page: 4226
  year: 2005
  end-page: 4235
  ident: bib24
  publication-title: J. Immunol.
– volume: 39
  start-page: 1632
  year: 2009
  end-page: 1641
  ident: bib20
  publication-title: Eur. J. Immunol.
– volume: 42
  start-page: 489
  year: 2005
  end-page: 494
  ident: bib1
  publication-title: Mol. Immunol.
– volume: 294
  start-page: 15
  year: 2004
  end-page: 22
  ident: bib17
  publication-title: J. Immunol. Methods.
– volume: 176
  start-page: 4646
  year: 2006
  end-page: 4650
  ident: bib22
  publication-title: J. Immunol.
– volume: 317
  start-page: 428
  year: 1985
  end-page: 430
  ident: bib33
  publication-title: Nature.
– volume: 148
  start-page: 2023
  year: 1992
  end-page: 2029
  ident: bib34
  publication-title: J. Immunol.
– volume: 173
  start-page: 174
  year: 2004
  end-page: 180
  ident: bib11
  publication-title: J. Immunol.
– volume: 105
  start-page: 180
  year: 2006
  end-page: 184
  ident: bib21
  publication-title: Immunol. Lett.
– volume: 184
  start-page: 2761
  year: 2010
  end-page: 2768
  ident: bib27
  publication-title: J. Immunol.
– volume: 179
  start-page: 8009
  year: 2007
  end-page: 8015
  ident: bib38
  publication-title: J. Immunol.
– volume: 42
  start-page: 419
  year: 2005
  end-page: 423
  ident: bib8
  publication-title: Mol. Immunol.
– volume: 114
  start-page: 2657
  year: 2009
  end-page: 2666
  ident: bib29
  publication-title: Blood.
– volume: 29
  start-page: 209
  year: 2001
  end-page: 220
  ident: bib4
  publication-title: Exp. Hematol.
– volume: 167
  start-page: 6706
  year: 2001
  end-page: 6710
  ident: bib10
  publication-title: J. Immunol.
– volume: 115
  start-page: 2167
  year: 2010
  end-page: 2176
  ident: bib28
  publication-title: Blood.
– volume: 296
  start-page: G671
  year: 2009
  end-page: G677
  ident: bib36
  publication-title: Am. J. Physiol. Gastrointest. Liver Physiol.
– volume: 162
  start-page: 6981
  year: 1999
  end-page: 6985
  ident: bib13
  publication-title: J. Immunol.
– volume: 190
  start-page: 1383
  year: 1999
  end-page: 1392
  ident: bib32
  publication-title: J. Exp. Med.
– volume: 214
  start-page: 22
  year: 2006
  end-page: 34
  ident: bib2
  publication-title: Immunol. Rev.
– volume: 107
  start-page: 3181
  year: 2006
  end-page: 3188
  ident: bib7
  publication-title: Blood.
– volume: 175
  start-page: 2045
  year: 2005
  end-page: 2049
  ident: bib9
  publication-title: J. Immunol.
– volume: 199
  start-page: 1245
  year: 2004
  end-page: 1254
  ident: bib12
  publication-title: J. Exp. Med.
– volume: 174
  start-page: 800
  year: 2005
  end-page: 807
  ident: bib3
  publication-title: J. Immunol.
– volume: 37
  start-page: 193
  year: 2007
  end-page: 198
  ident: bib41
  publication-title: Eur. J. Immunol.
– volume: 185
  start-page: 521
  year: 2009
  end-page: 534
  ident: bib35
  publication-title: J. Cell Biol.
– volume: 29
  start-page: 1676
  year: 1999
  end-page: 1683
  ident: bib14
  publication-title: Eur. J. Immunol.
– volume: 92
  start-page: 6728
  year: 1995
  end-page: 6732
  ident: bib16
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
– volume: 102
  start-page: 1745
  year: 2003
  end-page: 1752
  ident: bib30
  publication-title: Blood.
– volume: 162
  start-page: 6981
  year: 1999
  ident: 10.1074/jbc.M110.137976_bib13
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.162.12.6981
– volume: 296
  start-page: G671
  year: 2009
  ident: 10.1074/jbc.M110.137976_bib36
  publication-title: Am. J. Physiol. Gastrointest. Liver Physiol.
  doi: 10.1152/ajpgi.90497.2008
– volume: 115
  start-page: 2167
  year: 2010
  ident: 10.1074/jbc.M110.137976_bib28
  publication-title: Blood.
  doi: 10.1182/blood-2009-08-238469
– volume: 180
  start-page: 8159
  year: 2008
  ident: 10.1074/jbc.M110.137976_bib42
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.180.12.8159
– volume: 18
  start-page: 241
  year: 2006
  ident: 10.1074/jbc.M110.137976_bib19
  publication-title: Int. Immunol.
  doi: 10.1093/intimm/dxh358
– volume: 105
  start-page: 180
  year: 2006
  ident: 10.1074/jbc.M110.137976_bib21
  publication-title: Immunol. Lett.
  doi: 10.1016/j.imlet.2006.02.006
– volume: 148
  start-page: 2023
  year: 1992
  ident: 10.1074/jbc.M110.137976_bib34
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.148.7.2023
– volume: 103
  start-page: 10346
  year: 2006
  ident: 10.1074/jbc.M110.137976_bib25
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.0604236103
– volume: 179
  start-page: 8009
  year: 2007
  ident: 10.1074/jbc.M110.137976_bib38
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.179.12.8009
– volume: 199
  start-page: 1245
  year: 2004
  ident: 10.1074/jbc.M110.137976_bib12
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20031989
– volume: 175
  start-page: 4226
  year: 2005
  ident: 10.1074/jbc.M110.137976_bib24
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.175.7.4226
– volume: 37
  start-page: 193
  year: 2007
  ident: 10.1074/jbc.M110.137976_bib41
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.200636341
– volume: 175
  start-page: 2045
  year: 2005
  ident: 10.1074/jbc.M110.137976_bib9
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.175.4.2045
– volume: 45
  start-page: 3446
  year: 2008
  ident: 10.1074/jbc.M110.137976_bib40
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2008.03.021
– volume: 178
  start-page: 1397
  year: 1993
  ident: 10.1074/jbc.M110.137976_bib5
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.178.4.1397
– volume: 167
  start-page: 6706
  year: 2001
  ident: 10.1074/jbc.M110.137976_bib10
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.167.12.6706
– volume: 92
  start-page: 6728
  year: 1995
  ident: 10.1074/jbc.M110.137976_bib16
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.92.15.6728
– volume: 190
  start-page: 1383
  year: 1999
  ident: 10.1074/jbc.M110.137976_bib32
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.190.10.1383
– volume: 42
  start-page: 489
  year: 2005
  ident: 10.1074/jbc.M110.137976_bib1
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2004.07.032
– volume: 294
  start-page: 15
  year: 2004
  ident: 10.1074/jbc.M110.137976_bib17
  publication-title: J. Immunol. Methods.
  doi: 10.1016/j.jim.2004.08.008
– volume: 214
  start-page: 22
  year: 2006
  ident: 10.1074/jbc.M110.137976_bib2
  publication-title: Immunol. Rev.
  doi: 10.1111/j.1600-065X.2006.00453.x
– volume: 29
  start-page: 209
  year: 2001
  ident: 10.1074/jbc.M110.137976_bib4
  publication-title: Exp. Hematol.
  doi: 10.1016/S0301-472X(00)00652-4
– volume: 41
  start-page: 161
  year: 2009
  ident: 10.1074/jbc.M110.137976_bib18
  publication-title: Exp. Mol. Med.
  doi: 10.3858/emm.2009.41.3.019
– volume: 184
  start-page: 2761
  year: 2010
  ident: 10.1074/jbc.M110.137976_bib27
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0901572
– volume: 105
  start-page: 4383
  year: 2005
  ident: 10.1074/jbc.M110.137976_bib15
  publication-title: Blood.
  doi: 10.1182/blood-2004-08-3269
– volume: 29
  start-page: 1676
  year: 1999
  ident: 10.1074/jbc.M110.137976_bib14
  publication-title: Eur. J. Immunol.
  doi: 10.1002/(SICI)1521-4141(199905)29:05<1676::AID-IMMU1676>3.0.CO;2-Y
– volume: 173
  start-page: 174
  year: 2004
  ident: 10.1074/jbc.M110.137976_bib11
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.173.1.174
– volume: 114
  start-page: 2657
  year: 2009
  ident: 10.1074/jbc.M110.137976_bib29
  publication-title: Blood.
  doi: 10.1182/blood-2009-01-201632
– volume: 188
  start-page: 2083
  year: 1998
  ident: 10.1074/jbc.M110.137976_bib6
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.188.11.2083
– volume: 102
  start-page: 1745
  year: 2003
  ident: 10.1074/jbc.M110.137976_bib30
  publication-title: Blood.
  doi: 10.1182/blood-2002-07-2206
– volume: 185
  start-page: 521
  year: 2009
  ident: 10.1074/jbc.M110.137976_bib35
  publication-title: J. Cell Biol.
  doi: 10.1083/jcb.200809136
– volume: 284
  start-page: 21280
  year: 2009
  ident: 10.1074/jbc.M110.137976_bib37
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M807053200
– volume: 105
  start-page: 4722
  year: 2005
  ident: 10.1074/jbc.M110.137976_bib39
  publication-title: Blood.
  doi: 10.1182/blood-2004-09-3796
– volume: 42
  start-page: 419
  year: 2005
  ident: 10.1074/jbc.M110.137976_bib8
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2004.07.021
– volume: 176
  start-page: 4646
  year: 2006
  ident: 10.1074/jbc.M110.137976_bib22
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.176.8.4646
– volume: 107
  start-page: 3181
  year: 2006
  ident: 10.1074/jbc.M110.137976_bib7
  publication-title: Blood.
  doi: 10.1182/blood-2005-01-0185
– volume: 39
  start-page: 1632
  year: 2009
  ident: 10.1074/jbc.M110.137976_bib20
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.200838733
– volume: 317
  start-page: 428
  year: 1985
  ident: 10.1074/jbc.M110.137976_bib33
  publication-title: Nature.
  doi: 10.1038/317428a0
– volume: 167
  start-page: 6210
  year: 2001
  ident: 10.1074/jbc.M110.137976_bib23
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.167.11.6210
– volume: 19
  start-page: 239
  year: 2007
  ident: 10.1074/jbc.M110.137976_bib31
  publication-title: Int. Immunol.
  doi: 10.1093/intimm/dxl141
– volume: 174
  start-page: 800
  year: 2005
  ident: 10.1074/jbc.M110.137976_bib3
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.174.2.800
– volume: 110
  start-page: 2020
  year: 2007
  ident: 10.1074/jbc.M110.137976_bib26
  publication-title: Blood.
  doi: 10.1182/blood-2007-02-076927
SSID ssj0000491
Score 2.1237214
Snippet Human natural killer (NK) cells express an abundant level of 2B4 and CD2 on their surface. Their counter-receptors, CD48 and CD58, are also expressed on the NK...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 41755
SubjectTerms 2B4
Animals
Antigens, CD - biosynthesis
Antigens, CD - chemistry
CD2
CD2 Antigens - chemistry
CD48
CD48 Antigen
CD58
CD58 Antigens - biosynthesis
Cell Proliferation
Cell-Cell Interaction
Cellular Immune Response
Humans
Immunity, Innate
Immunology
Innate Immunity
Interferon-gamma - metabolism
Interleukin-2 - metabolism
K562 Cells
Killer Cells, Natural - metabolism
Leukocytes, Mononuclear - cytology
Lymphocyte Activation
Mice
NK Cells
Receptors
Receptors, Immunologic - chemistry
Signaling Lymphocytic Activation Molecule Family
Title Homotypic Cell to Cell Cross-talk Among Human Natural Killer Cells Reveals Differential and Overlapping Roles of 2B4 and CD2
URI https://dx.doi.org/10.1074/jbc.M110.137976
https://www.ncbi.nlm.nih.gov/pubmed/20813844
https://www.proquest.com/docview/821488103
https://www.proquest.com/docview/874180677
https://pubmed.ncbi.nlm.nih.gov/PMC3009903
Volume 285
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FcoALgpZHeGkPCCEhl9i79trHEkBRUYsQqZSb5V2v1SiNE1EHKYg_wL9mZtZOXNMg4GJH-3CifJ_Hs96Zbxh7UWh4MAjjeypSuSdFEHs6l9LLhQpMEUtt6dXAyWk0OpPHk3DS6_1sRS2tKn1ovl-bV_I_qEIb4IpZsv-A7Oai0ACfAV84AsJw_CuMRxhKt15OzWt8_45uJJ3pyeeBVz2rawm5Qnyk4QmIzCj9j4binsE3iwrKTaGUalqLB2Bo50W2pHQqDEGkkI_graTO4bug7dVu88vIs3XCTk56pKknt93rn7v8mtL7NOs0jjPrHU_LTutptkaL1Gn9Ak04of3WwkWA1ObeOksLvh-mEUzapjhw5XtqzoWiZVkl-DnhtTYfnCC0-docnvhUyEMlrqRMiwHLOVEgAAdIxE5wsiOz3XTdYDcDpWjH_-PnrfA8LKT8RhlKyTedb0NJ6Xr-Lv_m9_VLNwy35deM77I7NWz8yLHrHuvZcp8dHAFZFvM1f8kpRJj2XvbZrWED5wH7sSEfRybxauHOW_JxIh8n8vGafNyRj4Ze8pp8vE0-DvziLfJxIh9fFBzIR51Avvvs7MP78XDk1aU8PCOVrLwkzE2RFTKyMg-1DaUJRSETI000MMZGRitfYf1Z32gbm8SGmdBRbuIcFsCJX4gHbK9clPYR47G2QZLjdjz4ziKMtSqK2OYiSwZWycz02WEDQGpqnXsst3KRUryFkimAlyJ4qQOvz15tJiydxMvuoUGDaFp7qM7zTIGMuyfxBvsUMMI_OCvtYnWZxoEPz09_IP4wBNWlUOWxzx46tmx-Y8O4PlNXeLQZgMrxV3vK6TkpyAtcGA7E453XfMJub-_ap2yv-rqyz8D7rvRzui9-AbbZ3S4
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Homotypic+cell+to+cell+cross-talk+among+human+natural+killer+cells+reveals+differential+and+overlapping+roles+of+2B4+and+CD2&rft.jtitle=The+Journal+of+biological+chemistry&rft.au=Kim%2C+Eun-Ok&rft.au=Kim%2C+Tae-Jin&rft.au=Kim%2C+Nayoung&rft.au=Kim%2C+Sung+Tae&rft.date=2010-12-31&rft.eissn=1083-351X&rft.volume=285&rft.issue=53&rft.spage=41755&rft_id=info:doi/10.1074%2Fjbc.M110.137976&rft_id=info%3Apmid%2F20813844&rft.externalDocID=20813844
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9258&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9258&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9258&client=summon